HCPCS Level II › Q codes › Q2053
Q2053
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
ValidHCPCS Level II code.
Valid for claims with a date of service in the current code year.